Wednesday 24 September 2008

Introducing VAVELTA® - Treatment for Acne Scarring and Other Scars

Mulberry House Clinic has been chosen as one of a select group of treatment centres for VAVELTA®, a unique treatment for improving the structure, function and appearance of skin that has been damaged by scarring and the aging process.

Scarring occurs following injury to the skin following conditions such as acne, trauma or burns. The healing process produces new collagen, but scarring results when it is not laid down in exactly the same way as in the original skin.

VAVELTA® is a suspension of human dermal fibroblast cells which are injected into the skin to replace those lost through skin damage. A series of shallow injections are used to place the cells just under the uppermost layer of skin where they would normally be found.

The cells establish themselves and start to remodel the scarred tissue with new collagen so that improvement occurs over weeks or a few months with a very natural result. No other procedure is available that offers this approach of matching your own skin’s structure.

Dr John Tanqueray of Mulberry House Clinic comments: “Scarring has always been a challenging area to treat successfully. Initial results with Vavelta are extremely encouraging, and we are delighted that we can now offer our clients Vavelta alongside the other beauty treatment options we have. An added bonus is that Vavelta is a relatively straightforward treatment to have and unlike many other treatments after-effects are minimal.”

How can I find out more about VAVELTA®?

This procedure can only be performed by a specialist physician who is a member of the VAVELTA® Clinical Practice Group. To obtain more information please visit www.vavelta.com

VAVELTA® is just one of a wide range of non-surgical cosmetic treatments offered at Mulberry House Clinic by Dr John Tanqueray. Appointments for initial consultation are offered free of charge.

Call 01604 702630 for an appointment or visit www.lasertreatmentsnorthampton.co.uk for more information.

No comments: